1-6 of 6
Hideki Asaoku, M.D.
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Voriconazole (VRCZ) Versus Itraconazole (ITCZ) As Antifungal Prophylaxis For Acute Myelogenus Leukemia (AML) and Acute Lymphoblastic Leukemia (ALL) Patients In Induction Therapy, Prospective Randomized Study

Kouhei Kyo, M.D., Mitsuhiro Itagaki, MD, Taiichi Kyo, MD, Takeshi Okatani, M.D., Tetsuro Ochi, Yuta Katayama, MD, PhD, Ryouta Imanaka, M.D., Kouji Iwato, Hideki Asaoku, M.D.
Journal: Blood
Blood (2013) 122 (21): 3897.
https://doi.org/10.1182/blood.V122.21.3897.3897
Published: 2013
Journal Articles

Improvement Of The Efficacy Of Azacitidine At a Fixed Dosing Schedule Of 75mg/m 2 /Day For 5 Days, Followed By 21 Days Drug-Off In Higher Risk Myelodysplastic Syndromes

Taiichi Kyo, M.D., Kouhei Kyo, MD, Ryouta Imanaka, M.D., Mitsuhiro Itagaki, MD, Tetsuro Ochi, Takeshi Okatani, M.D., Koji Iwato, MD, Yuta Katayama, MD, PhD, Hideki Asaoku, M.D.
Journal: Blood
Blood (2013) 122 (21): 1571.
https://doi.org/10.1182/blood.V122.21.1571.1571
Published: 2013
Journal Articles

Immunomodulatory Thalidomide Analogs Do Not Affect Osteoprogenitor Differentiation and Low Concentration of Bortezomib Promotes It, While Both Agents Suppress Osteoclast Differentiation.

Shoso Munemasa, MD, Akira Sakai, M.D., Yoshiaki Kuroda, M.D., Yoshiko Okikawa, M.D., Yuta Katayama, M.D., Hideki Asaoku, M.D., Tadahiko Kubo, M.D., Shoji Shimose, M.D., Akiro Kimura, M.D.
Journal: Blood
Blood (2007) 110 (11): 4780.
https://doi.org/10.1182/blood.V110.11.4780.4780
Published: 2007
Journal Articles

Cyclin D1 Overexpression Increases Chemosensitivity Via Prolonged S-Phase and TRAIL Signal in Myeloma Cell.

Yoshiaki Kuroda, MD, Akira Sakai, M.D., Naohiro Tsuyama, Ph.D., Yuta Katayama, M.D., Shoso Munemasa, M.D., Yoshiko Okikawa, M.D., Hideki Asaoku, M.D., Nanae Nakaju, Mami Mizuno, Takashi Nishizaka, M.D., Katsunari Ogawa, Hideo Tanaka, M.D., Akiro Kimura, M.D.
Journal: Blood
Blood (2007) 110 (11): 3530.
https://doi.org/10.1182/blood.V110.11.3530.3530
Published: 2007
Journal Articles

Connective Tissue Growth Factor (CTGF) Is an Indicator of Bone Involvement in Multiple Myeloma.

Shoso Munemasa, MD, Akira Sakai, M.D., Yoshiaki Kuroda, M.D., Yoshiko Okikawa, M.D., Yuta Katayama, M.D., Hideki Asaoku, M.D., Tadahiko Kubo, M.D., Noelynn Oliver, Ph.D., Akiro Kimura, M.D.
Journal: Blood
Blood (2006) 108 (11): 5025.
https://doi.org/10.1182/blood.V108.11.5025.5025
Published: 2006
Journal Articles

What Is Important Factor of Bone Disease in Multiple Myeloma?.

Shoso Munemasa, M.D., Akira Sakai, M.D., Yoshiko Okikawa, M.D., Yoshiaki Kuroda, M.D., Yuta Katayama, M.D., Hideki Asaoku, M.D., Akiro Kimura, M.D.
Journal: Blood
Blood (2004) 104 (11): 4855.
https://doi.org/10.1182/blood.V104.11.4855.4855
Published: 2004